A new study in mice has revealed that a specific drug combined with a protein fragment can prevent the growth of blood cancer cells.
This research focused on multiple myeloma, a type of cancer that originates in blood cells responsible for fighting infections through the production of germ-eliminating proteins. In this disease, cancerous cells accumulate in the bone marrow, displacing healthy blood cells and generating defective proteins. Initially, the disease may present without symptoms, but as it progresses, individuals often suffer from symptoms such as bone pain, nausea, mental confusion, fatigue, and increased susceptibility to infections.
In about half of multiple myeloma cases, changes in the